Ionis Pharmaceuticals, Inc. Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31)
Ionis Pharmaceuticals, Inc. (IONS) reported Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) of $10.00 million for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-29.
Discontinued › Notes
us-gaap:MinorityInterestIncreaseFromStockIssuance · last filed 2012-02-29
- Ionis Pharmaceuticals, Inc. noncontrolling interest, increase from equity issuance or sale of parent equity interest (deprecated 2013-01-31) for fiscal 2009 was $10.00M, a 9900.00% increase from fiscal 2008.
- Ionis Pharmaceuticals, Inc. noncontrolling interest, increase from equity issuance or sale of parent equity interest (deprecated 2013-01-31) for fiscal 2008 was $100.00K.
| Period end | Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) 12 month |
|---|---|
| 2009-12-31 | $10.00M 10-K · filed 2012-02-29 |
| 2008-12-31 | $100.00K 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |